Pages that link to "Q36733611"
Jump to navigation
Jump to search
The following pages link to Screening of male dialysis patients for fabry disease by plasma globotriaosylsphingosine (Q36733611):
Displaying 14 items.
- The importance of medical interview with CKD patient in diagnoses of a family with Fabry disease (Q33622175) (← links)
- Fabry nephropathy: a review - how can we optimize the management of Fabry nephropathy? (Q33645550) (← links)
- A symptomatic Fabry disease mouse model generated by inducing globotriaosylceramide synthesis (Q34159448) (← links)
- Variations in the GLA gene correlate with globotriaosylceramide and globotriaosylsphingosine analog levels in urine and plasma. (Q36691965) (← links)
- A new mutation found in newborn screening for Fabry disease evaluated by plasma globotriaosylsphingosine levels (Q37643909) (← links)
- Prevalence of Fabry disease in dialysis patients: Japan Fabry disease screening study (J-FAST). (Q41562385) (← links)
- Fabry disease in children: a federal screening programme in Russia. (Q42066201) (← links)
- Screening of Fabry disease in patients with end-stage renal disease of unknown etiology: the first Thailand study (Q42136169) (← links)
- Role of the p.E66Q variant of GLA in the progression of chronic kidney disease (Q44491007) (← links)
- Prevalence of Fabry disease and GLA c.196G>C variant in Japanese stroke patients (Q47835191) (← links)
- Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis (Q64046067) (← links)
- High-risk screening for Anderson-Fabry disease in patients with cardiac, renal, or neurological manifestations. (Q64910987) (← links)
- Determination of globotriaosylceramide analogs in the organs of a mouse model of Fabry disease (Q90370824) (← links)
- Rare inherited kidney diseases: an evolving field in Nephrology (Q90750202) (← links)